Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers
- PMID: 28851056
- PMCID: PMC5761331
- DOI: 10.1002/jmv.24930
Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers
Abstract
The burden of influenza infections in patients with hematological malignancies (HMs) is not well defined. We describe the clinical presentation and associated outcomes of influenza at two comprehensive cancer centers (center 1 in the United States and center 2 in Mexico). Clinical and laboratory data on patients with HMs and influenza infection diagnosed from April 2009 to May 2014 at the two centers were reviewed retrospectively. A total of 190 patients were included, the majority were male (63%) with a median age of 49 years (range, 1-88 years), and had active or refractory HMs (76%). Compared to center 1, patients in center 2 were significantly sicker (active cancer, decreased albumin levels, elevated creatinine levels, or hypoxia at influenza diagnosis) and experienced higher lower respiratory tract infection (LRI) rate (42% vs 7%; P < 0.001). In multivariable logistic regression analysis (odds ratio, 95% confidence interval), leukemia, (3.09, 1.23-7.70), decreased albumin level (3.78, 1.55-9.20), hypoxia at diagnosis (14.98, 3.30-67.90), respiratory co-infection (5.87, 1.65-20.86), and corticosteroid use (2.71, 1.03-7.15) were significantly associated with LRI; and elevated creatinine level (3.33, 1.05-10.56), hypoxia at diagnosis (5.87, 1.12-30.77), and respiratory co-infection (6.30, 1.55-25.67) were significantly associated with 60 day mortality in both centers. HM patients with influenza are at high risk for serious complications such as LRI and death, especially if they are immunosuppressed. Patients with respiratory symptoms should seek prompt medical care during influenza season.
Keywords: H1N1; cancer; influenza; leukemia; lymphoma; myeloma; pneumonia.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
Figures
References
-
- Cordero E, de la Torre-Cisneros J, Moreno A, Pérez-Romero P, Riera M. The impact of influenza A(H1N1) pandemic 2009 infection in immunosuppressed patients. Enferm Infecc Microbiol Clin. 2012;30:38–42. - PubMed
-
- Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, et al. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatric Infectious Disease Journal. 2012;31(4):373–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
